| AI | Artificial Intelligence |
| CT | Computed Tomography |
| MRI | Magnetic Resonance Imaging |
| PET | Positron Emission Tomography |
| DL | Deep Learning |
| IPF | Idiopathic Pulmonary Fibrosis |
| CPFE | Combined Pulmonary Fibrosis and Emphysema |
| QIN | Quantitative Imaging Network |
| VTD | Volume Doubling Time |
| SSPNs | Small Solitary Pulmonary Nodules |
| AUC | Area Under the Curve |
| HRCT | High-Resolution Computed Tomography |
| CNN | Convolutional Neural Networks |
| CAD | Computer-Aided Detection/Diagnosis |
| NLST | National Lung Screening Trial |
| EGFR | Epidermal Growth Factor Receptor |
| NSCLC | Non-Small Cell Lung Carcinoma |
| GTV | Gross-Tumor Volume |
| TKI | Tyrosine Kinase Inhibitors |
| COPD | Chronic Obstructive Pulmonary Disease |
| HU | Hounsfield Unit |
| PRM | Parametric Response Mapping |
| PFTs | Pulmonary Function Tests |
| LVR | Lung Volume Reduction |
| ICS | Inhaled Corticosteroids |
| ILD | Interstitial Lung Diseases |
| NSIP | Non-Specific Interstitial Pneumonia |
| CALIPER | Computer-Aided Lung Informatics for Pathology Evaluation and Rating |
| FVC | Forced Vital Capacity |
| QLF | Quantitative Lung Fibrosis |
| PH | Pulmonary Hypertension |
| PAH | Pulmonary Arterial Hypertension |
| RHC | Right Heart Catheterization |
| ROI | Region of Interest |